AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 43 filers reported holding AVADEL PHARMACEUTICALS PLC in Q4 2019. The put-call ratio across all filers is 0.93 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,861,600 | +332.9% | 260,000 | +203.2% | 0.10% | +284.0% |
| Q3 2022 | $430,000 | -77.7% | 85,758 | -89.1% | 0.02% | -77.7% |
| Q2 2022 | $1,926,000 | +62.4% | 789,181 | +347.9% | 0.11% | +202.7% |
| Q2 2021 | $1,186,000 | -44.0% | 176,206 | -24.7% | 0.04% | -38.3% |
| Q1 2021 | $2,116,000 | -18.7% | 234,122 | -39.9% | 0.06% | -36.8% |
| Q4 2020 | $2,602,000 | -35.1% | 389,571 | -51.0% | 0.10% | -54.1% |
| Q3 2020 | $4,008,000 | -11.9% | 795,200 | +41.3% | 0.21% | -52.6% |
| Q2 2020 | $4,547,000 | +15.3% | 562,800 | +13.3% | 0.44% | -6.6% |
| Q1 2020 | $3,943,000 | +379.1% | 496,660 | +355.7% | 0.47% | +550.0% |
| Q4 2019 | $823,000 | +63.0% | 109,000 | -10.2% | 0.07% | -16.3% |
| Q3 2019 | $505,000 | – | 121,435 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 1,625,000 | $12,269,000 | 3.04% |
| GENDELL JEFFREY L | 1,146,764 | $8,658,000 | 1.11% |
| Broadfin Capital, LLC | 1,029,012 | $7,769,000 | 1.04% |
| RTW INVESTMENTS, LP | 3,401,434 | $25,681,000 | 0.97% |
| BRANDES INVESTMENT PARTNERS, LP | 3,651,948 | $27,571,000 | 0.66% |
| Aristides Capital LLC | 71,520 | $540,000 | 0.42% |
| Tekla Capital Management LLC | 814,588 | $6,150,000 | 0.23% |
| INVESTORS ASSET MANAGEMENT OF GEORGIA INC /GA/ /ADV | 36,100 | $273,000 | 0.17% |
| Leap Investments LP | 43,481 | $328,000 | 0.15% |
| Brown Capital Management | 1,829,886 | $13,816,000 | 0.13% |